Skip to content

Dose-dependent Effects of Oxytocin on the Amygdala and Reward System

Dose-dependent Effects of Oxytocin on the Amygdala and Reward System Vary Between Women and Men

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03846739
Enrollment
92
Registered
2019-02-20
Start date
2017-04-03
Completion date
2018-12-31
Last updated
2019-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

amygdala, reward, oxytocin, dose, emotion processing, sex differences

Brief summary

The purpose of this study is to determine whether effects of intranasal oxytocin on amygdala and reward system responses vary as a function of treatment dose in women in comparison to men.

Detailed description

The objective of the present study is to determine whether intranasal oxytocin (IN-OXT) effects on blood oxygenation level-dependent functional magnetic resonance imaging (BOLD fMRI) in the amygdala and striatal regions (putamen, nucleus accumbens, caudate, pallidum) vary as a function of dose. In particular, the investigators plan to compare effects of three different IN-OXT doses (6, 12, and 24 international units, IU) on established neural and behavioural correlates of emotion processing in women. Results will be discussed in comparison to a previous study of OXT kinetics in men.

Interventions

DRUGOxytocin nasal spray

Intranasal administration, 6, 12, or 24 international units (IU) oxytocin.

DRUGPlacebo

The placebo nasal sprays contain identical ingredients except for the peptide itself.

Sponsors

University Hospital, Bonn
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy female volunteers * Right-handed * Non-smoker

Exclusion criteria

* Current psychiatric or physical illness * Hormonal contraception * Psychoactive medication * MRI contraindication (e.g. metal in body, claustrophobia) * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Neural substrates of emotion processing, measured via blood-oxygen-level dependent signal in the amygdala45 min after nasal spray administrationFunctional magnetic resonance imaging (fMRI) will be performed to measure blood-oxygen-level dependent signal in response to emotional face stimuli. The investigators specifically plan to investigate amygdala responses to emotional faces, because previous studies found sex-specific effects of oxytocin on amygdala activation.
Neural substrates of emotion processing, measured via blood-oxygen-level dependent signal in striatal regions (putamen, nucleus accumbens, caudate, pallidum)45 min after nasal spray administrationFunctional magnetic resonance imaging (fMRI) will be performed to measure blood-oxygen-level dependent signal in response to emotional face stimuli. The investigators specifically plan to investigate striatal responses to emotional faces to explore sex-specific effects of OXT on reward-related brain activation.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026